Viruses and human cancer.
作者信息
Liao John B
机构信息
Department of Obstetrics, Gynecology, and Reproductive Services, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
出版信息
Yale J Biol Med. 2006 Dec;79(3-4):115-22.
Abstract
摘要
相似文献
1
Viruses and human cancer.
Yale J Biol Med. 2006 Dec;79(3-4):115-22.
2
Viruses and human cancer: from detection to causality.
Cancer Lett. 2011 Jun 28;305(2):218-27. doi: 10.1016/j.canlet.2010.09.011. Epub 2010 Oct 23.
3
Recent Highlights: Onco Viral Exploitation of the SUMO System.
Curr Issues Mol Biol. 2020;35:1-16. doi: 10.21775/cimb.035.001. Epub 2019 Aug 18.
4
Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation.
Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):304-25. doi: 10.1002/em.20088.
5
Regulation of telomerase and telomeres: human tumor viruses take control.
J Natl Cancer Inst. 2008 Jan 16;100(2):98-108. doi: 10.1093/jnci/djm269. Epub 2008 Jan 8.
6
Human tumor-associated viruses and new insights into the molecular mechanisms of cancer.
Oncogene. 2008 Dec;27 Suppl 2:S31-42. doi: 10.1038/onc.2009.351.
7
Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.
Mediators Inflamm. 2014;2014:564296. doi: 10.1155/2014/564296. Epub 2014 Nov 30.
8
[Human Oncogenic Viruses: Old Facts and New Hypotheses].
Mol Biol (Mosk). 2019 Sep-Oct;53(5):871-880. doi: 10.1134/S0026898419050033.
9
Viruses and cancer. Causal associations.
Ann Epidemiol. 1990 Oct;1(1):71-92. doi: 10.1016/1047-2797(90)90020-s.
10
Viruses and human cancer.
N Engl J Med. 1972 Jan 13;286(2):70-82. doi: 10.1056/NEJM197201132860206.
引用本文的文献
1
Mathematical models and computational approaches in CAR-T therapeutics.
Front Immunol. 2025 Aug 1;16:1581210. doi: 10.3389/fimmu.2025.1581210. eCollection 2025.
2
Graphene-Based Photodynamic Therapy and Overcoming Cancer Resistance Mechanisms: A Comprehensive Review.
Int J Nanomedicine. 2024 Jun 11;19:5637-5680. doi: 10.2147/IJN.S461300. eCollection 2024.
3
Friend or Foe: Exploring the Relationship between the Gut Microbiota and the Pathogenesis and Treatment of Digestive Cancers.
Microorganisms. 2024 May 8;12(5):955. doi: 10.3390/microorganisms12050955.
4
High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia.
PLoS One. 2024 Mar 20;19(3):e0298583. doi: 10.1371/journal.pone.0298583. eCollection 2024.
5
Efficient Estimates of Surface Diffusion Parameters for Spatio-Temporally Resolved Virus Replication Dynamics.
Int J Mol Sci. 2024 Mar 5;25(5):2993. doi: 10.3390/ijms25052993.
6
RNA-Seq Virus Fraction in Lake Baikal and Treated Wastewaters.
Int J Mol Sci. 2023 Jul 27;24(15):12049. doi: 10.3390/ijms241512049.
7
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities.
Mol Pharm. 2023 Aug 7;20(8):3698-3740. doi: 10.1021/acs.molpharmaceut.2c01080. Epub 2023 Jul 24.
8
Metagenomic Analysis of DNA Viruses with Targeted Sequence Capture of Canine Lobular Orbital Adenomas and Normal Conjunctiva.
Microorganisms. 2023 Apr 28;11(5):1163. doi: 10.3390/microorganisms11051163.
9
Splicing Characterization and Isoform Switch Events in Human Keratinocytes Carrying Oncogenes from High-Risk HPV-16 and Low-Risk HPV-84.
Int J Mol Sci. 2023 May 6;24(9):8347. doi: 10.3390/ijms24098347.
10
Directed Evolution of Seneca Valley Virus in Tumorsphere and Monolayer Cell Cultures of a Small-Cell Lung Cancer Model.
Cancers (Basel). 2023 Apr 28;15(9):2541. doi: 10.3390/cancers15092541.
本文引用的文献
1
Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients.
J Immunol. 2006 Oct 15;177(8):5718-26. doi: 10.4049/jimmunol.177.8.5718.
2
Prevention of mortality from hepatitis B and hepatitis C.
Lancet. 2006 Sep 9;368(9539):896-7. doi: 10.1016/S0140-6736(06)69347-1.
3
Treating viral hepatitis C: efficacy, side effects, and complications.
Gut. 2006 Sep;55(9):1350-9. doi: 10.1136/gut.2005.076646.
4
The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
HIV Med. 2006 Sep;7(6):369-77. doi: 10.1111/j.1468-1293.2006.00395.x.
5
Treating hepatitis C infection in liver transplant recipients.
Liver Transpl. 2006 Aug;12(8):1192-204. doi: 10.1002/lt.20865.
6
Advances in HTLV-1 peptide vaccines and therapeutics.
Curr Protein Pept Sci. 2006 Apr;7(2):137-45. doi: 10.2174/138920306776359803.
7
Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment.
J Infect Dis. 2006 Apr 1;193(7):971-7. doi: 10.1086/500839. Epub 2006 Mar 1.
8
The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
Cancer Res. 2006 Jan 1;66(1):168-74. doi: 10.1158/0008-5472.CAN-05-1026.
9
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
Hepatology. 2005 Apr;41(4):847-56. doi: 10.1002/hep.20657.
10
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.
Lancet. 2004;364(9447):1757-65. doi: 10.1016/S0140-6736(04)17398-4.
Zotero 插件